Abstract
The November 10th was instituted as the World HTLV Day by the International Retrovirology Association (IRVA), aiming informing and mobilizing the society and the public authorities on the significance of this infection caused by the first known human retrovirus, the human T-cell lymphotropic virus type 1 (HTLV-1). The associated diseases, the impact in the public health, and the means to block its transmission were reviewed. Considering that Brazil, the country in the Latin America, has been presenting the highest number of HTLV-1-infected individuals, this text was written for giving the relevant information concerning the HTLV-1 infection to the scientific community.
References
1. Paiva A, Casseb J. Sexual transmission of human T-cell lymphotropic virus type 1. Rev Soc Bras Med Trop. 2014;47(3):265-74. http://dx.doi.org/10.1590/0037-8682-0232-2013
2. Ministério da Saúde (BR). Portaria no 1.376, de 19 de novembro de 1993. Aprova alterações na Portaria no 721/GM, de 9 de agosto de 1989, que aprova normas técnicas para coleta, processamento e transfusão de sangue, componentes e derivados, e da outras providências. Diário Oficial da União. Brasília, DF, 2 dez 1993. Disponível em: http://sna.saude.gov.br/legisla/legisla/hemo/GM_P1376_93hemo.doc
3. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. http://dx.doi.org/ 10.3389/fmicb.2012.00388
4. Hino S. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Sci. 2011;87(4):152-66. http://dx.doi.org/ 10.2183/pjab.87.152
5. Caterino-de-Araujo A, Sacchi CT, Gonçalves MG, Campos KR, Magri MC, Alencar WK; Group of Surveillance and Diagnosis of HTLV of São Paulo (GSuDiHTLV-SP). Short Communication: Current prevalence and risk factors associated with HTLV-1 and HTLV-2 infections among HIV/AIDS patients in São Paulo, Brazil. AIDS Res Hum Retroviruses. 2015;31(5):543-9. http://dx.doi.org/10.1089/AID.2014.0287
6. Brites C, Alencar R, Gusmão R, Pedroso C, Neto EM, Pedral-Sampaio D et al. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS. 2001;15(15):2053-5. http://doi.org/10.1097/00002030-200110190-00023
7. Brites C, Sampaio J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009;11(1):8-16. Disponível em: http://www.aidsreviews.com/resumen.php?id=1030&indice=2009111&u=unp
8. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e Hepatites Virais. Protocolo clínico e diretrizes terapêuticas para manejo da infecção pelo HIV em adultos. Brasília (DF): Ministério da Saúde; 2018. 412p. Disponível em: http://www.aids.gov.br/pt-br/pub/2013/protocolo-clinico-e-diretrizes-terapeuticas-para-manejoda-infeccao-pelo-hiv-em-adultos
9. Castro E, Roger E. Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: regional burden and virological outcomes in people who inject drugs. World J Virol. 2016;5(2):68-72. http://dx.doi.org/10.5501/wjv. v5.i2.68
10. Alves FA, Campos KR, Lemos MF, Moreira RC, Caterino-de-Araujo A. Hepatitis C viral load in HCVmonoinfected and HCV/HIV-1, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2- co-infected patients from São Paulo, Brazil. Braz J Infect Dis. 2018;22(2):123-8. http://dx.doi.org/10.1016/j.bjid.2018.03.002
11. Ministério da Saúde (BR). Comissão Nacional de Incorporação de Tecnologias do SUS. Relatório de recomendação nº 220 Junho/2016. Western Blot e PCR em tempo real em pacientes com leucemia/linfoma de células T do adulto associado ao HTLV-1. Disponível em: http://conitec.gov.br/images/Relatorios/2016/Relatorio_WesternBlot-PCR_HTLV_final.pdf
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2018 Adele caterino de Araujo